Maine LD107 would require health insurance coverage for biomarker testing.

Maine LD107 would require health insurance coverage for biomarker testing, including coverage in the MaineCare program. Biomarker testing involves analyzing a patient's tissue, blood, or other biological specimen for the presence of a biomarker. The bill mandates coverage for biomarker testing when supported by medical and scientific evidence, such as FDA-approved tests or FDA drug labels. It also requires prompt approval or denial of prior authorization requests for biomarker testing.

Maine LD107 would require health insurance coverage for biomarker testing.

Maine LD107 would require health insurance coverage for biomarker testing, including coverage in the MaineCare program. Biomarker testing involves analyzing a patient's tissue, blood, or other biological specimen for the presence of a biomarker. The bill mandates coverage for biomarker testing when supported by medical and scientific evidence, such as FDA-approved tests or FDA drug labels. It also requires prompt approval or denial of prior authorization requests for biomarker testing.